Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 3, 1996, Pages 573-584

  Perez, Carlos A ^a,c   Michalski, Jeff ^a   Brown, Kathryn C ^b   Lockett, Mary Ann ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Radiation Oncology Center   (United States)

Author keywords

Pelvic lymph node irradiation; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; DISEASE-FREE SURVIVAL; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PELVIS; PROSTATIC NEOPLASMS; RADIATION INJURIES;

EID: 0030271698     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00378-1     Document Type: Article

References (41)

1. 1. Asbell, S. O.; Caplan, R. J.; Perez, C. A.; Rubin, P.; Doggett, R. L.; Sause, W. T.; Rotman, M.; Emami, B.; Shin, K.; Pilepich, M. V. Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG phase III study for T1b-T2NOMO prostatic carcinoma: RTOG #77-06. Proc. ASCO. Am. J. Clin. Oncol. 14:512; 1995.
2. 2. Asbell, S. O.; Krall, J. M.; Pilepich, M.; Baerwald, H.; Sause, W. T.; Hanks, G. E.; Perez, C. A. Elective pelvic irradiation in stage A2, B carcinoma of the prostate: Analysis of RTOG 77-06. J. Radiat. Oncol. Biol. Phys. 15:1307-1316; 1988.
3. 3. Bagshaw, M. A. Radiotherapeutic treatment of prostatic carcinoma with pelvic lymph node involvement. Urol. Clin. North Am. 11:297-303; 1984.
4. 4. Batata, M. A.; Hilaris, B. S.; Chu, F. C. H.; Whitmore, W. F.; Song, H. S.; Kim, Y.; Horowitz, B.; Song, K. S. Radiation therapy in adenocarcinoma of the prostate with pelvic lymph node involvement on lymphadenectomy. Int. J. Radiat. Oncol. Biol. Phys. 6:149-153; 1980.
5. 5. Beahrs, O. H.; Henson, D. E.; Hutter, R. V. P.; Kennedy, B. J., eds. Manual for staging of cancer, 4th ed. Philadelphia: J. B. Lippincott; 1992:181-183.
6. 6. Bluestein, D. L.; Bostwick, D. G.; Bergstralh, E. J.; Oesterling, J. E. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J. Urol. 151:1315-1320; 1994.
7. 7. Corn, B. W.; Hanks, G. E.; Schultheiss, T. E.; Hunt, M. A.; Lee, W. R.; Coia, L. R. Conformal treatment of prostate cancer with improved targeting: Superior prostate-specific antigen response compared to standard treatment. Int. J. Radiat. Oncol. Biol. Phys. 32:325-330; 1995.
8. 8. Cutler, S. J.; Ederer, F. Maximum utilization of the life table method for analyzing survival. J. Chron. Dis. 8:699-713; 1958.
9. 9. Dixon, W. J., ed. BMDP statistical software. Los Angeles: University of California Press; 1982.
10. 10. Dixon, W. J., ed. NEWS for 1987 release of BMDP statistical software. Los Angeles: University of California Press; 1986.
11. 11. Gervasi, L. A.; Mata, J.; Easley, J. D.; Wilbanks, J. H.; Seale-Hawkins, C.; Carlton, C. E., Jr.; Scardino, P. T. Prognostic significance of lymph nodal metastases in prostate cancer. J. Urol. 142:333-336; 1989.
12. 12. Gleason, D. F. Veterans Administration Cooperative Urological Research Group Histologie grading and clinical staging of prostate carcinoma. In: Tannenbaum, M., ed. Urologic pathology: The prostate. Philadelphia: J. B. Lippincott; 1977:171-198.
13. 13. Hanks, G. E. Optimizing the radiation treatment and outcome of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 11:1235-1246; 1985.
14. 14. Hanks, G. E.; Schultheiss, T. E.; Hunt, M. A.; Epstein, B. Factors influencing incidence of acute grade 2 morbidity in conformai and standard radiation treatment of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 31:25-29; 1995.
15. 125I implant and pelvic node dissection. Int. J. Radiat. Oncol. Biol. Phys. 2:631-637; 1977.
16. 16. Hill, D.; Crews, A. D., Jr; Walsh, P. C. Prostate carcinoma: Radiation treatment of the primary and regional lymphatics. Cancer 34:156-159; 1974.
17. 17. Jønler, M.; Ritter, M. A.; Brinkmann, R.; Messing, E. M.; Rhodes, P. R.; Bruskewitz, R. C. Sequelae of definitive radiation therapy for prostate cancer localized to the pelvis. Urology 44:876-882; 1994.
18. 18. Kurup, P.; Kramer, T. S.; Phillips, R. External beam irradiation of prostate cancer: Experience in 163 patients. Cancer 53:37-43; 1984.
19. 19. McGowan, D. G. The value of extended field radiation therapy in carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 7:1333-1339; 1981.
20. 20. Miller, R. Survival analysis. New York: John Wiley and Sons; 1981.
21. 21. Partin, A. W.; Yoo, J.; Carter, H.; Pearson, J. D.; Chan, D. W.; Epstein, J. L; Walsh, P. C. The use of prostate specific antigen, clinical stage, and Gleason score to predict pathologic stage in men with localized prostate cancer. J. Urol. 150:110-114; 1993.
22. 22. Perez, C. A. Carcinoma of the prostate: A model for management under impending health care reform. Radiology 196:309-322; 1995.
23. 23. Perez, C. A. Prostate. In: Perez, C. A.; Brady, L. W., eds. Principles and practice of radiation oncology. 2nd ed. Philadelphia: J. B. Lippincott; 1992:1067-1116.
24. 24. Perez, C. A.; Ackerman, L. V.; Silber, I.; Royce, R. K. Radiation therapy in the treatment of localized carcinoma of the prostate: Preliminary report using 22 MeV photons. Cancer 34:1059-1968; 1974.
25. 25. Perez, C. A.; Eisbruch, A. Role of postradical prostatectomy irradiation in carcinoma of the prostate. Semin. Oncol. 3:198-209; 1993.
26. 26. Perez, C. A.; Garcia, D.; Simpson, J. R.; Zivnuska, F.; Lockett, M. A. Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate. Radiother. Oncol. 16:1-21; 1989.
27. 27. Perez, C. A.; Lee, H. K.; Georgiou, A.; Lockett, M. A. Technical factors influencing morbidity in definitive irradiation for localized carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 28:811-819; 1994.
28. 28. Perez, C. A.; Pilepich, M. V.; Garcia, D.; Simpson, J. R.; Zivnuska, F. Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: Experience at the Mallinckrodt Institute of Radiology. NCI Monogr. 7:85-94; 1988.
29. 29. Perez, C. A.; Pilepich, M. V.; Zivnuska, F. Tumor control in definitive irradiation for localized carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 12:523-531; 1986.
30. 30. Perez, C. A.; Purdy, J. A.; Harms, W.; Gerber, R.; Graham, M. V.; Matthews, J. W.; Bosch, W.; Drzymala, R.; Emami, B.; Fox, S.; Klein, E.; Lee, H. K.; Michalski, J. M.; Simpson, J. Three-dimensional treatment planning and conformal radiation therapy: Preliminary evaluation. Radiother. Oncol. 36:32-43; 1995.
31. 31. Pilepich, M. V.; Krall, J. M.; Sause, W. T.; Johnson, R. J.; Russ, H, H.; Hanks, G. E.; Perez, C. A.; Zinninger, M.; Martz, K. L. Prognostic factors in carcinoma of the prostate: Analysis of RTOG study 75-06. Int. J. Radiat. Oncol. Biot. Phys. 13:339-349; 1987.
32. 32. Pistenma, D. A.; Bagshaw, M. A.; Freiha, F. S. Extended-field radiation therapy for prostatic adenocarcinoma: Status report of a limited prospective trial. In: Johnson, D. E.; Samuels, M. L., eds. Cancer of the genitourinary tract. New York: Raven Press; 1979:229-247.
33. 33. Ploysongsang, S. S.; Aron, B. S.; Shehata, W. M. Radiation therapy in prostate cancer: Whole pelvis with prostate boost or small field to prostate? Urology 40:18-26; 1992.
34. 34. Prout, G. R., Jr.; Heaney, J. A.; Griffin, P.; Daly, J. J.; Shipley, W. U. Nodal involvement as a prognostic indicator in patients with prostatic carcinoma. J. Urol. 124:226-231; 1980.
35. 35. Rangala, N.; Cox, J. D.; Byhardt, R. W.; Wilson, J. P.; Greenberg, M.; Lopes da Conceicao, A. Local control and survival after external irradiation for adenocarcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 8:1909-1914; 1982.
36. 36. Roach, M., III; Krall, J.; Keller, J. W.; Perez, C. A.; Sause, W. T.; Doggert, R. L. S.; Rotman, M.; Russ, H.; Pilepich, M. V.; Asbell, S. O.; Shipley, W. The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985). Int. J. Radiat. Oncol. Biol. Phys. 24:441-449; 1992.
37. 37. Smith, J. A., Jr.; Haynes, T. H.; Middleton, R. G. Impact of external irradiation on local symptoms and survival free of disease in patients with pelvic lymph node metastasis from adenocarcinoma of the prostate. J. Urol. 131:705-707; 1984.
38. 38. Smith, J. A., Jr.; Middleton, R. G. Implications of volume of nodal metastasis in patients with adenocarcinoma of the prostate. J. Urol. 133:617-619; 1985.
39. 39. Spaas, P. G.; Bagshaw, M. A.; Cox, R. S. The value of extended field irradiation in surgically staged carcinoma of the prostate (abstract). Int. J. Radiat, Oncol. Biol. Phys. 15(Suppl. 1):133; 1988.
40. 40. Tarone, R. Tests for trend in life table analysis. Biometrika 62:679-682; 1975.
41. 41. Tarone, R.; Ware, J. On distribution free tests for equality of survival distributions. Biometrika 64:156-160; 1977.